Detalhe da pesquisa
1.
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
J Virol
; 96(13): e0038322, 2022 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699445
2.
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants.
Nat Commun
; 13(1): 2674, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562337
3.
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2.
Cell Discov
; 8(1): 17, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169113
4.
Novel Reassortant Avian Influenza A(H5N6) Viruses in Humans, Guangdong, China, 2015.
Emerg Infect Dis
; 22(8): 1507-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27331418
5.
Kinetic Characteristics of Neutralizing Antibody Responses Vary among Patients with COVID-19.
Biomed Environ Sci
; 34(12): 976-983, 2021 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981720
6.
Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates.
ACS Nano
; 15(2): 2738-2752, 2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464829
7.
Exploring utility of genomic epidemiology to trace origins of highly pathogenic influenza A/H7N9 in Guangdong.
Virus Evol
; 6(2): veaa097, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391821
8.
[Cloning and analysis of full-length genes of a H9N2 subtype avian influenza virus isolated from Guangdong].
Bing Du Xue Bao
; 26(3): 176-82, 2010 May.
Artigo
em Zh
| MEDLINE | ID: mdl-20572337